Company intelligence / Profile preview

ClearCut Medical

Rehovot, Central, Israelclrcut.com ↗

Ownership: Private
Development stage: Commercial

Overview

ClearCut Medical has developed the ClearCoast™ MRI System, which provides real-time intraoperative margin analysis of surgically removed breast tumors. Clinical trials involving over 400 patients have demonstrated excellent accuracy compared to gold standard histopathology and suggest an 80% reduction in re-excision rates during breast-conserving surgery. The company is exploring additional indications beyond breast cancer.

Therapeutic areas: Oncology
Modalities: DeviceImaging technology (specifically MRI-based intraoperative margin assessment)
Industry: Medical Imaging

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on ClearCut Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClearCut Medical.

Explore the full profile